Steven Gilman

Steven Gilman

Director/Board Member bei AKEBIA THERAPEUTICS, INC.

Vermögen: 600 484 $ am 31.03.2024

71 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Steven C.
Gilman
is an Independent Director at Vericel Corp., SCYNEXIS, Inc., and Akebia Therapeutics, Inc. He is also a Director at Biotechnology Association of Alabama, Massachusetts Society for Medical Research, Inc., PhRMA Foundation, Transcelerate Biopharma, Inc., and Lakes Environmental Association.
Previously, he served as Chairman & Chief Executive Officer at ActivBiotics, Inc., Vice Chairman at ContraFect Corp., Biology Director at Jazz Pharmaceuticals (EUSA Pharma USA), Inc., Independent Director at Keryx Biopharmaceuticals, Inc. and Momenta Pharmaceuticals, Inc., Group Director-Global Research & Development at Pfizer (St. Louis), Executive Director at Inhibikase Therapeutics, Inc., Scientist at Wyeth LLC, Vice President & General Manager-Inflammation at Millennium Pharmaceuticals, Inc., and Chief Scientific Officer & Executive VP-Research at Cubist Pharmaceuticals LLC.
He also served as a Principal at Connecticut College, Inflammation Research Association, Inc., and Temple University School of Medicine.
He received his undergraduate degree from Miami University and his graduate and doctorate degrees from The Pennsylvania State University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
08.03.2024 7 800 ( 0,02% ) 405 756 $ 31.03.2024
06.06.2023 87 130 ( 0,04% ) 159 448 $ 31.03.2024
15.06.2023 24 000 ( 0,06% ) 35 280 $ 31.03.2024
06.09.2023 26 ( 0,00% ) 1 $ 31.03.2024

Aktive Positionen von Steven Gilman

UnternehmenPositionBeginn
VERICEL CORPORATION Director/Board Member 06.01.2015
SCYNEXIS, INC. Director/Board Member 25.02.2015
AKEBIA THERAPEUTICS, INC. Director/Board Member 12.12.2018
Director/Board Member -
Director/Board Member -
Director/Board Member -
Massachusetts Society for Medical Research, Inc. Director/Board Member 07.07.2009
Lakes Environmental Association Director/Board Member -
Alle aktiven Positionen von Steven Gilman

Ehemalige bekannte Positionen von Steven Gilman

UnternehmenPositionEnde
CONTRAFECT CORPORATION Chief Executive Officer 02.04.2019
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Steven Gilman im Detail an

Ausbildung von Steven Gilman

Miami University Undergraduate Degree
The Pennsylvania State University Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Steven Gilman im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
VERICEL CORPORATION

Health Technology

SCYNEXIS, INC.

Health Technology

AKEBIA THERAPEUTICS, INC.

Health Technology

CONTRAFECT CORPORATION

Health Technology

INHIBIKASE THERAPEUTICS, INC.

Health Technology

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Massachusetts Society for Medical Research, Inc.

Commercial Services

Health Technology

Lakes Environmental Association

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Steven Gilman